Charles River Laboratories
CRL
Charles River Laboratories (CRL) - Cash on Hand
Cash on Hand as of December 2023 : $0.27 B
According to Charles River Laboratories
's latest financial reports the company has $0.27 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Charles River Laboratories - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | 18.32% |
| 2022-12-31 | $0.23 B | -3.03% |
| 2021-12-31 | $0.24 B | 5.13% |
| 2020-12-31 | $0.22 B | -3.98% |
| 2019-12-31 | $0.23 B | 21.71% |
| 2018-12-31 | $0.19 B | 2.1% |
| 2017-12-31 | $0.19 B | 58.39% |
| 2016-12-31 | $0.12 B | -12.33% |
| 2015-12-31 | $0.13 B | -21.41% |
| 2014-12-31 | $0.17 B | 5.45% |
| 2013-12-31 | $0.16 B | 43.46% |
| 2012-12-31 | $0.11 B | 56.83% |
| 2011-12-31 | $74.26 M | -60.71% |
| 2010-12-31 | $0.18 B | -20.59% |
| 2009-12-31 | $0.23 B | -2.29% |
| 2008-12-31 | $0.24 B | 1.32% |
| 2007-12-31 | $0.24 B | 31.49% |
| 2006-12-31 | $0.18 B | 56.94% |
| 2005-12-31 | $0.11 B | -43.94% |
| 2004-12-31 | $0.20 B | 6.3% |
| 2003-12-31 | $0.19 B | 59.57% |
| 2002-12-31 | $0.12 B | 110.24% |
| 2001-12-31 | $58.27 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $8.07 B | 2,818.30% | 🇺🇸 USA |
 SCYNEXIS SCYX | $88.07 M | -68.18% | 🇺🇸 USA |
 Repligen
RGEN | $0.75 B | 171.46% | 🇺🇸 USA |